Alyeska Investment Group, L.P. 89bio, Inc. Transaction History

Alyeska Investment Group, L.P.

$25.4 Billion
Q2 2025

A detailed history of Alyeska Investment Group, L.P. transactions in 89bio, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 576,973 shares of ETNB stock, worth $8.54 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

576,973

Previous 852,227 32.3%

Holding current value

$8.54 Million

Previous $6.2 Million 8.56%

% of portfolio

0.02%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$4.83 - $10.57 $1.33 Million - $2.91 Million	-275,254 Reduced 32.3%	576,973 $5.67 Million
Q1 2025 May 15, 2025	SELL	$6.18 - $11.66 $452,190 - $853,162	-73,170 Reduced 7.91%	852,227 $6.2 Million
Q4 2024 Feb 14, 2025	BUY	$7.03 - $10.05 $821,335 - $1.17 Million	116,833 Added 14.45%	925,397 $7.1 Million
Q3 2024 Nov 14, 2024	BUY	$7.36 - $9.66 $63,031 - $82,728	8,564 Added 1.07%	808,564 $5.98 Million
Q2 2024 Aug 14, 2024	BUY	$7.31 - $10.9 $3.66 Million - $5.45 Million	500,000 Added 166.67%	800,000 $6.41 Million
Q1 2024 May 15, 2024	SELL	$8.13 - $13.77 $2.3 Million - $3.9 Million	-283,187 Reduced 48.56%	300,000 $3.49 Million
Q4 2023 Feb 14, 2024	BUY	$6.66 - $16.03 $1.65 Million - $3.98 Million	248,300 Added 74.14%	583,187 $6.51 Million
Q2 2023 Aug 14, 2023	BUY	$14.15 - $22.03 $19,838 - $30,886	1,402 Added 0.42%	334,887 $6.35 Million
Q1 2023 May 15, 2023	BUY	$10.48 - $16.94 $3.49 Million - $5.65 Million	333,485 New	333,485 $5.08 Million
Q2 2022 Aug 15, 2022	BUY	$2.09 - $4.02 $518,936 - $998,145	248,295 Added 480.21%	300,000 $966,000
Q3 2021 Nov 15, 2021	BUY	$14.91 - $21.31 $34,293 - $49,013	2,300 Added 4.66%	51,705 $1.01 Million
Q1 2021 May 17, 2021	SELL	$20.22 - $26.73 $505,500 - $668,250	-25,000 Reduced 33.6%	49,405 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$23.16 - $28.08 $184,608 - $223,825	-7,971 Reduced 9.68%	74,405 $1.81 Million
Q3 2020 Nov 16, 2020	SELL	$24.34 - $38.82 $902,235 - $1.44 Million	-37,068 Reduced 31.03%	82,376 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$19.75 - $33.44 $2.36 Million - $3.99 Million	119,444 New	119,444 $3.14 Million

Others Institutions Holding ETNB

# of Institutions

213

Shares Held

160M

Call Options Held

299K

Put Options Held

1.61M

View Full List

About 89bio, Inc.

Ticker ETNB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,484,500
Market Cap $688M
Description
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...

More about ETNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. 89bio, Inc. Transaction History